SCHEMBL30989793

SCHEMBL30989793

CN(Cc1cc(F)cc(Cl)c1)C(=O)c1cc(Cl)cnc1OC(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.38
▸ CLK1 P49759 1/20 0.36
▸ CLK2 P49760 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ TACR1 P25103 5/20 0.35
▸ DAO P14920 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ PTGER4 P35408 3/20 0.33
▸ PTGER2 P43116 2/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ GPBAR1 Q8TDU6 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30989808 0.96 HTT (0.39) HTTCLK1CLK2DYRK1ATACR1
SCHEMBL30989912 0.92 HTT (0.37) HTTCLK1CLK2DYRK1ATACR1
SCHEMBL30989813 0.88 CLK1 (0.43) CLK1CLK2DYRK1ATACR1HSP90AA1
SCHEMBL30989923 0.88 ALDH1A1 (0.47) HTTCLK1CLK2DYRK1AHSP90AA1
SCHEMBL30989806 0.85 GRM5 (0.45) HTTDYRK1ATACR1HSP90AA1GRM5
SCHEMBL30989886 0.83 CLK1 (0.44) CLK1CLK2DYRK1ATACR1HSP90AA1
SCHEMBL30989812 0.82 MEP1B (0.44) HTTDAOHSP90AA1GRM5ALDH1A1
SCHEMBL30989925 0.81 RIPK1 (0.42) HTTPTGER4PTGER2SCN9A
SCHEMBL30989857 0.81 HSP90AA1 (0.52) HTTTACR1HSP90AA1GRM5KMT2A
SCHEMBL30989922 0.80 POLB (0.49) ALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612131-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2025-09-10 — — EP claimed
WO-2024095003-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2024-05-10 — — WO claimed
EP-4612131-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024095003-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2024-05-10 — — WO disclosed
Send feedback